Cardinal Health

Cardinal Health, a US-based Drugs and Druggists' Sundries Merchant Wholesalers company, reported total emissions of approximately 20.14 billion kg CO2e in 2025. This includes Scope 1 emissions of approximately 154.39 million kg CO2e, Scope 2 emissions of approximately 197.85 million kg CO2e, and Scope 3 emissions of approximately 19.79 billion kg CO2e. In 2024, the company's total emissions were approximately 22.27 billion kg CO2e, with Scope 1 at about 160.15 million kg CO2e, Scope 2 at approximately 204.72 million kg CO2e, and Scope 3 at about 21.91 billion kg CO2e. For 2023, Cardinal Health's Scope 1 emissions were approximately 163.04 million kg CO2e, Scope 2 (market-based) were about 220.68 million kg CO2e, and Scope 3 emissions were approximately 21.36 billion kg CO2e.

Cardinal Health has committed to ambitious climate targets. The company aims to reduce absolute Scope 1 and 2 GHG emissions by 50% by fiscal year 2030, using a fiscal year 2019 baseline. This near-term target is validated by the Science Based Targets initiative (SBTi) as consistent with a 1.5°C warming scenario. Furthermore, Cardinal Health commits that 75% of its suppliers by spend, covering purchased goods and services and upstream transportation and distribution, will have science-based targets by fiscal year 2028.